Martin Klein1,2, Heřman Mann1,2, Jiří Vencovský3,4. 1. Institute of Rheumatology, Na Slupi 4, 128 50, Prague, Czech Republic. 2. Department of Rheumatology, 1st Medical Faculty, Charles University, Prague, Czech Republic. 3. Institute of Rheumatology, Na Slupi 4, 128 50, Prague, Czech Republic. vencovsky@revma.cz. 4. Department of Rheumatology, 1st Medical Faculty, Charles University, Prague, Czech Republic. vencovsky@revma.cz.
Abstract
PURPOSE OF REVIEW: Arthritis is a well-recognized symptom of idiopathic inflammatory myopathies (IIM). We provide a summary of available data regarding the epidemiology, clinical characteristics, and autoantibody associations of joint involvement in various forms of IIM. RECENT FINDINGS: Arthritis is reported in 18-55% of patients with IIM. It is particularly frequent (20-70%) in those with antisynthetase syndrome (ASS); highest prevalence is associated with anti-Jo-1 positivity. Most common manifestation is non-erosive polyarthritis. X-ray erosions may be found occasionally in ASS, particularly in patients with overlap with rheumatoid arthritis (RA). Arthritis is often present at the time of IIM diagnosis and it may even precede the onset of muscle weakness. Arthritis may in some cases be the main disease manifestation responsible for the disease burden in patients with IIM. Arthritis is a frequent symptom of IIM. Polyarthritis of small joints of the hands is the most frequent clinical manifestation. Arthritis may be the first or dominant symptom in IIM and therefore patients may be initially misdiagnosed as having RA. Particularly in seronegative RA patients with interstitial lung disease or Raynaud's phenomenon, the possibility of IIM should be considered.
PURPOSE OF REVIEW: Arthritis is a well-recognized symptom of idiopathic inflammatory myopathies (IIM). We provide a summary of available data regarding the epidemiology, clinical characteristics, and autoantibody associations of joint involvement in various forms of IIM. RECENT FINDINGS:Arthritis is reported in 18-55% of patients with IIM. It is particularly frequent (20-70%) in those with antisynthetase syndrome (ASS); highest prevalence is associated with anti-Jo-1 positivity. Most common manifestation is non-erosive polyarthritis. X-ray erosions may be found occasionally in ASS, particularly in patients with overlap with rheumatoid arthritis (RA). Arthritis is often present at the time of IIM diagnosis and it may even precede the onset of muscle weakness. Arthritis may in some cases be the main disease manifestation responsible for the disease burden in patients with IIM. Arthritis is a frequent symptom of IIM. Polyarthritis of small joints of the hands is the most frequent clinical manifestation. Arthritis may be the first or dominant symptom in IIM and therefore patients may be initially misdiagnosed as having RA. Particularly in seronegative RApatients with interstitial lung disease or Raynaud's phenomenon, the possibility of IIM should be considered.
Authors: Miguel A González-Gay; Carlomaurizio Montecucco; Albert Selva-O'Callaghan; Ernesto Trallero-Araguas; Ovynd Molberg; Helena Andersson; Jorge Rojas-Serrano; Diana Isabel Perez-Roman; Jutta Bauhammer; Christoph Fiehn; Rossella Neri; Simone Barsotti; Hannes M Lorenz; Andrea Doria; Anna Ghirardello; Florenzo Iannone; Margherita Giannini; Franco Franceschini; Ilaria Cavazzana; Konstantinos Triantafyllias; Maurizio Benucci; Maria Infantino; Mariangela Manfredi; Fabrizio Conti; Andreas Schwarting; Giandomenico Sebastiani; Annamaria Iuliano; Giacomo Emmi; Elena Silvestri; Marcello Govoni; Carlo Alberto Scirè; Federica Furini; Francisco Javier Lopez-Longo; Julia Martínez-Barrio; Marco Sebastiani; Andreina Manfredi; Javier Bachiller-Corral; Walter Alberto Sifuentes Giraldo; Marco A Cimmino; Claudio Cosso; Alessandro Belotti Masserini; Giovanni Cagnotto; Veronica Codullo; Mariaeva Romano; Giuseppe Paolazzi; Raffaele Pellerito; Lesley Ann Saketkoo; Norberto Ortego-Centeno; Luca Quartuccio; Alberto Batticciotto; Elena Bartoloni Bocci; Roberto Gerli; Christof Specker; Elena Bravi; Carlo Selmi; Simone Parisi; Fausto Salaffi; Federica Meloni; Enrico Marchioni; Alberto Pesci; Giulia Dei; Marco Confalonieri; Paola Tomietto; Laura Nuno; Francesco Bonella; Nicolò Pipitone; Antonio Mera-Valera; Nair Perez-Gomez; Simone Gerzeli; Raquel Lopez-Mejias; Carlo Jorge Matos-Costa; Jose Antonio Pereira da Silva; José Cifrian; Claudia Alpini; Ignazio Olivieri; María Ángeles Blázquez Cañamero; Ana Belén Rodriguez Cambrón; Santos Castañeda; Lorenzo Cavagna Journal: Clin Exp Rheumatol Date: 2017-07-26 Impact factor: 4.473
Authors: Maria Casal-Dominguez; Iago Pinal-Fernandez; Andrea M Corse; Julie Paik; Jemima Albayda; Livia Casciola-Rosen; Cheilonda Johnson; Sonye K Danoff; Lisa Christopher-Stine; Eleni Tiniakou; Andrew L Mammen Journal: Neurology Date: 2019-03-01 Impact factor: 9.910
Authors: Rebecca De Lorenzo; Iago Pinal-Fernandez; Wilson Huang; Jemima Albayda; Eleni Tiniakou; Cheilonda Johnson; Jose C Milisenda; Maria Casal-Dominguez; Andrea M Corse; Sonye K Danoff; Lisa Christopher-Stine; Julie J Paik; Andrew L Mammen Journal: Neurology Date: 2018-05-04 Impact factor: 9.910
Authors: Moisés Labrador-Horrillo; Ma Angeles Martinez; Albert Selva-O'Callaghan; Juan Francisco Delgado; Xavier Martínez-Gómez; Ernesto Trallero-Araguás; Jose Luis Rodriguez-Sanchez; Miquel Vilardell-Tarrés Journal: Rheumatology (Oxford) Date: 2009-04-22 Impact factor: 7.580
Authors: Vito Crincoli; Mariangela Cannavale; Angela Pia Cazzolla; Mario Dioguardi; Maria Grazia Piancino; Mariasevera Di Comite Journal: Int J Med Sci Date: 2021-07-05 Impact factor: 3.738
Authors: Matthew Wells; Sughra Alawi; Kyaing Yi Mon Thin; Harsha Gunawardena; Adrian R Brown; Anthony Edey; John D Pauling; Shaney L Barratt; Huzaifa I Adamali Journal: Front Med (Lausanne) Date: 2022-09-14